These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3791222)

  • 1. Suppression of hypertriglyceridemia of Ehrlich carcinoma-bearing mice by an antibiotic, ascofuranone.
    Magae J; Hosokawa T; Matsuda Y; Hotta M; Hayasaki J; Nagai K; Ando K; Yamasaki M; Tamura G
    Cancer Res; 1987 Jan; 47(1):96-9. PubMed ID: 3791222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hypolipidemic action of ascofuranone in hepatoblastoma G2 cell culture].
    Trenin AS
    Antibiot Khimioter; 1999; 44(9):7-9. PubMed ID: 10511901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor and antimetastatic activity of an antibiotic, ascofuranone, and activation of phagocytes.
    Magae J; Hayasaki J; Matsuda Y; Hotta M; Hosokawa T; Suzuki S; Nagai K; Ando K; Tamura G
    J Antibiot (Tokyo); 1988 Jul; 41(7):959-65. PubMed ID: 3417568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor protective property of an isoprenoid antibiotic, ascofuranone.
    Magae J; Hosokawa T; Ando K; Nagai K; Tamura G
    J Antibiot (Tokyo); 1982 Nov; 35(11):1547-52. PubMed ID: 7161193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ascofuranone suppresses PMA-mediated matrix metalloproteinase-9 gene activation through the Ras/Raf/MEK/ERK- and Ap1-dependent mechanisms.
    Cho HJ; Kang JH; Kwak JY; Lee TS; Lee IS; Park NG; Nakajima H; Magae J; Chang YC
    Carcinogenesis; 2007 May; 28(5):1104-10. PubMed ID: 17114644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the rates of lipogenesis and hepatic triglyceride secretion in mice bearing Ehrlich ascites carcinoma.
    Bálint Z; Szikla K; Holczinger L
    In Vivo; 1989; 3(2):129-33. PubMed ID: 2519840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of natural cytotoxic activity and concomitant reduction of triglyceride content of murine spleen, treated with an antitumor antibiotic, ascofuranone.
    Magae J; Hotta M; Nagai K; Suzuki S; Ando K; Yamasaki M; Tamura G
    J Antibiot (Tokyo); 1986 May; 39(5):676-81. PubMed ID: 3733517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ascofuranone stimulates expression of adiponectin and peroxisome proliferator activated receptor through the modulation of mitogen activated protein kinase family members in 3T3-L1, murine pre-adipocyte cell line.
    Chang YC; Cho HJ
    Biochem Biophys Res Commun; 2012 Jun; 422(3):423-8. PubMed ID: 22580003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ascofuranone suppresses EGF-induced HIF-1α protein synthesis by inhibition of the Akt/mTOR/p70S6K pathway in MDA-MB-231 breast cancer cells.
    Jeong YJ; Cho HJ; Magae J; Lee IK; Park KG; Chang YC
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):542-50. PubMed ID: 24096035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertriglyceridemia in Ehrlich ascites carcinomatous mice: tumor and mouse strain differences.
    Kannan R; Baker N
    Lipids; 1977 Feb; 12(2):153-8. PubMed ID: 846297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipolytic activity in adipose tissue of mice bearing Ehrlich ascites carcinoma.
    Bálint Z
    Cancer Biochem Biophys; 1991 Jun; 12(1):45-52. PubMed ID: 1769004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypolipidemic property of ascofuranone.
    Sawada M; Hosokawa T; Okutomi T; Ando K
    J Antibiot (Tokyo); 1973 Nov; 26(11):681-6. PubMed ID: 4792116
    [No Abstract]   [Full Text] [Related]  

  • 13. Ascofuranone prevents ER stress-induced insulin resistance via activation of AMP-activated protein kinase in L6 myotube cells.
    Hwang SL; Chang HW; Lee IK; Yang BK; Magae J; Chang YC
    Biochem Biophys Res Commun; 2010 Jun; 396(4):967-72. PubMed ID: 20460103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Turnover and transport of plasma very-low-density lipoprotein triglycerides in mice bearing Ehrlich ascites carcinoma.
    Lyon I; Kannan R; Ookhtens M; Baker N
    Cancer Res; 1982 Jan; 42(1):132-8. PubMed ID: 7053841
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of dietary fat and hepatic triglyceride secretion in cancer-induced hypertriglyceridemia.
    Kannan R; Wilson L; Baker N
    Lipids; 1978 Dec; 13(12):887-91. PubMed ID: 750829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor extracellular triglycerides in mice during growth of Ehrlich ascites carcinoma.
    Kannan R; Baker N
    Lipids; 1975 Dec; 10(12):770-2. PubMed ID: 1207413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapeutic efficacy of ascofuranone in Trypanosoma vivax-infected mice without glycerol.
    Yabu Y; Suzuki T; Nihei C; Minagawa N; Hosokawa T; Nagai K; Kita K; Ohta N
    Parasitol Int; 2006 Mar; 55(1):39-43. PubMed ID: 16288933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of plasma-free fatty acid mobilization by dietary glucose in Ehrlich ascites tumor-bearing mice.
    Baker N; Hill V; Ookhtens M
    Cancer Res; 1978 Aug; 38(8):2372-7. PubMed ID: 667834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antitumor effects of tetrodotoxin and/or doxorubicin on Ehrlich ascites carcinoma-bearing female mice.
    El-Dayem SM; Fouda FM; Ali EH; Motelp BA
    Toxicol Ind Health; 2013 Jun; 29(5):404-17. PubMed ID: 22317827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemfibrozil treatment of endogenous hypertriglyceridemia: effect on insulin-mediated glucose disposal and plasma insulin concentrations.
    Jeng CY; Sheu WH; Fuh MM; Shieh SM; Chen YD; Reaven GM
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2550-3. PubMed ID: 8675576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.